Our data demonstrate that (i) the kidney function in diabetic-cancer patients treated with cisplatin is significantly preserved by using DPP-4 inhibitors, and (ii) the incidence of AKI is reduced by these drugs. Here, DPP4 is linked to acute kidney injury.